During the past decade, CHR Metz-Thionville Hôpital de Mercy conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHR Metz-Thionville Hôpital de Mercy" #1 sponsor was "Centre Hospitalier Régional Metz-Thionville" with 10 trials, followed by "Central Hospital, Nancy, France" with 2 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "French Innovative Leukemia Organisation" with 2 trials sponsored and "French Society for Intensive Care" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHR Metz-Thionville Hôpital de Mercy" #1 collaborator was "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "CHR Metz-Thionville Hôpital de Mercy" are "Multiple Myeloma" (3 trials), "Intensive Care Unit Syndrome" (2 trials), "ALK Gene Mutation" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials) and "Adapted Physical Activity" (1 trials). Many other conditions were trialed in "CHR Metz-Thionville Hôpital de Mercy" in a lesser frequency.

Most popular intervention types in "CHR Metz-Thionville Hôpital de Mercy" are "Drug" (15 trials), "Other" (11 trials), "Device" (5 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Identification of predictive factors" (2 trials), "Paclitaxel" (2 trials), "1.3 BETA D GLUCAN" (1 trials), "APA associated with biofeedback relaxation" (1 trials) and "APA with Exergaming device" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHR Metz-Thionville Hôpital de Mercy" are 38 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CHR Metz-Thionville Hôpital de Mercy". undefined are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in CHR Metz-Thionville Hôpital de Mercy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHR Metz-Thionville Hôpital de Mercy, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".